---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-22-001024"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2022-05-16T23:59:59+00:00"
generated_at: "2026-06-25T14:55:51.607709+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences enters $20M common stock purchase agreement with Lincoln Park Capital

## Summary
- Company may sell up to $20M of common stock over 36 months at discounts of 3-5% to market price.
- Lincoln Park received 292,968 commitment shares as consideration for entering the agreement.
- Proceeds from any sales will be used for working capital and general corporate purposes; company has no obligation to sell.
- Regular purchases limited to 200,000 shares per day, increased if stock price exceeds $0.50 or $0.75, max $1M per purchase.
- Accelerated purchases allowed at 95% of closing or VWAP, with additional accelerated purchases possible on same day.

## SEC filing metadata
- accession: 0001640334-22-001024
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2022-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033422001024/0001640334-22-001024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033422001024/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-22-001024
- JSON: https://secwatch.observer/filing/0001640334-22-001024.json
- Plain text: https://secwatch.observer/filing/0001640334-22-001024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.